B A Usmani

776 total citations
18 papers, 624 citations indexed

About

B A Usmani is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, B A Usmani has authored 18 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in B A Usmani's work include Peptidase Inhibition and Analysis (8 papers), CRISPR and Genetic Engineering (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). B A Usmani is often cited by papers focused on Peptidase Inhibition and Analysis (8 papers), CRISPR and Genetic Engineering (5 papers) and Nitric Oxide and Endothelin Effects (3 papers). B A Usmani collaborates with scholars based in United Kingdom, United States and Japan. B A Usmani's co-authors include Anthony J. Turner, Christos N. Papandreou, David M. Nanus, Norman J. Maitland, Howard I. Scher, Yiping Geng, Anthony P. Albino, Connie L. Finstad, C. Thomas Powell and Ronald H. Freeman and has published in prestigious journals such as Nature Medicine, Annals of the New York Academy of Sciences and British Journal of Cancer.

In The Last Decade

B A Usmani

18 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B A Usmani United Kingdom	12	318	239	182	141	130	18	624
Satsuki Matsushima Japan	19	536 1.7×	173 0.7×	226 1.2×	85 0.6×	91 0.7×	38	1.0k
R Shen United States	12	354 1.1×	187 0.8×	155 0.9×	33 0.2×	90 0.7×	17	566
Cristina T. Kesler United States	12	350 1.1×	121 0.5×	187 1.0×	25 0.2×	92 0.7×	13	563
Christiane Maier Germany	18	406 1.3×	118 0.5×	430 2.4×	41 0.3×	190 1.5×	32	963
José Manuel Pacheco García Spain	13	443 1.4×	430 1.8×	98 0.5×	34 0.2×	190 1.5×	27	779
Martina Witsch‐Baumgartner Austria	16	835 2.6×	208 0.9×	134 0.7×	33 0.2×	105 0.8×	36	1.3k
Muayad F. Almahariq United States	12	268 0.8×	125 0.5×	77 0.4×	41 0.3×	140 1.1×	33	616
Prodipto Pal Canada	17	306 1.0×	248 1.0×	388 2.1×	79 0.6×	166 1.3×	49	956
Hicham Lahlou France	13	335 1.1×	263 1.1×	40 0.2×	30 0.2×	60 0.5×	14	843
John C. Ringold United States	6	427 1.3×	396 1.7×	86 0.5×	43 0.3×	95 0.7×	7	943

Countries citing papers authored by B A Usmani

Since Specialization

Citations

This map shows the geographic impact of B A Usmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B A Usmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B A Usmani more than expected).

Fields of papers citing papers by B A Usmani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B A Usmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B A Usmani. The network helps show where B A Usmani may publish in the future.

Co-authorship network of co-authors of B A Usmani

This figure shows the co-authorship network connecting the top 25 collaborators of B A Usmani. A scholar is included among the top collaborators of B A Usmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B A Usmani. B A Usmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Turner, Anthony J., et al.. (2010). Herpesvirus saimiri‐based endothelin‐converting enzyme‐1 shRNA expression decreases prostate cancer cell invasion and migration. International Journal of Cancer. 129(3). 586–598. 11 indexed citations

Turner, Anthony J., et al.. (2008). Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion. British Journal of Cancer. 99(7). 1114–1120. 31 indexed citations

Usmani, B A, et al.. (2008). Design, Manufacture, and Assay of the Efficacy of siRNAs for Gene Silencing. Methods in molecular biology. 439. 403–419. 5 indexed citations

Maitland, Norman J., et al.. (2006). Expression and localization of endothelin-converting enzyme-1 in human prostate cancer.. PubMed. 231(6). 1106–10. 16 indexed citations

Awano, Shuji, et al.. (2005). Endothelin system in oral squamous carcinoma cells: Specific siRNA targeting of ECE‐1 blocks cell proliferation. International Journal of Cancer. 118(7). 1645–1652. 34 indexed citations

Maitland, Norman J., et al.. (2004). Stromal–epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression. British Journal of Cancer. 90(8). 1577–1582. 33 indexed citations

Maitland, Norman J., et al.. (2003). Stromal-epithelial interactions prostate cancer cell invasion by altering the balance of metallopeptidase expression. European Urology Supplements. 2(6). 153–153. 1 indexed citations

Usmani, B A, et al.. (2002). Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines. Clinical Science. 103(s2002). 314S–317S. 30 indexed citations

Shen, Ruoqian, Makoto Sumitomo, Dianne O. Hardy, et al.. (2000). Identification and characterization of two androgen response regions in the human neutral endopeptidase gene. Molecular and Cellular Endocrinology. 170(1-2). 131–142. 61 indexed citations

10.

Usmani, B A, et al.. (2000). Analysis of the insertion/deletion polymorphism of the human angiotensin converting enzyme (ACE) gene in patients with renal cancer. British Journal of Cancer. 82(3). 550–552. 15 indexed citations

11.

Usmani, B A, R Shen, Christos N. Papandreou, et al.. (2000). Methylation of the neutral endopeptidase gene promoter in human prostate cancers.. PubMed. 6(5). 1664–70. 67 indexed citations

12.

Papandreou, Christos N., B A Usmani, Yiping Geng, et al.. (1998). Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nature Medicine. 4(1). 50–57. 234 indexed citations

13.

Usmani, B A & Gajanan V. Sherbet. (1996). Homologous recombination in variants of the B16 murine melanoma with reference to their metastatic potential.. PubMed. 61(1). 1–8. 5 indexed citations

14.

Usmani, B A & Gajanan V. Sherbet. (1996). Homologous recombination in variants of the B16 murine melanoma with reference to their metastatic potential. Journal of Cellular Biochemistry. 61(1). 1–8. 2 indexed citations

15.

Sherbet, Gajanan V., et al.. (1995). Epidermal Growth Factor Receptor Status Correlates with Cell Proliferation—related 18A2/mts1 Gene Expression in Human Carcinoma Cell Lines^a. Annals of the New York Academy of Sciences. 768(1). 272–275. 8 indexed citations

16.

Usmani, B A, et al.. (1994). Induction of 18A2/mts1 Gene Expression and Its Effects on Metastasis and Cell Cycle Control. DNA and Cell Biology. 13(10). 1021–1028. 42 indexed citations

17.

Usmani, B A. (1993). Genomic Instability and Metastatic Progression. Pathobiology. 61(2). 109–116. 24 indexed citations

18.

Usmani, B A, John Lunec, & Gajanan V. Sherbet. (1993). DNA repair and repair fidelity in metastatic variants of the B16 murine melanoma. Journal of Cellular Biochemistry. 51(3). 336–344. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact